Science
Dr. George Greer on the Promise and Peril of Psychedelic Medicine
Show Notes:
* Dr. George Greer talks about the most interesting and important thing happening in the psychedelic world right now: the Bipartisan Congressional Psychedelics Advancing Therapies (PATH) Caucus. This caucus aims to pass legislation for a carve-out from the NIH budget to support psychedelic research. (03:46)
* Dr. Greer shares his pioneering research on MDMA-assisted couples therapy, which yielded insights and strengthened relationships with minimal side-effects. (07:00)
* Dr. Greer emphasizes the importance of mindset, setting, and therapy in achieving positive outcomes from psychedelic experiences. (12:30)
* Dr. Greer explains the difference between psychedelic and psycholytic therapy. (12:30)
* Dr. Greer talks about the risks and benefits of using psychedelics as a catalyst for growth and healing. (12:30)
* Dr. Greer stresses the importance of responsible use of psychedelics, including screening, preparation, and integration, to minimize harm and maximize benefit. (12:30)
* Dr. Greer talks about the potential unwanted psychological complications of psychedelic therapy, including psychosis and trauma. (12:30)
* Dr. Greer discusses the challenges of funding psychedelic research and the need for responsible guidance to realize the promise of this field. (12:30)
Links and Resources
* Heffter Research Institute
* Bipartisan Congressional Psychedelics Advancing Therapies Caucus
* MDMA Studies for PTSD Treatment (Multidisciplinary Association for Psychedelic Studies)
* Apollo Pact
* NYU Psilocybin Cancer Anxiety Study
Johns Hopkins Psilocybin Research:
* Mount Sinai Medicine PTSD Research
More Episodes
2021-03-02
2021-02-23
2021-02-16
2021-02-09
2021-02-02
2021-01-19
2021-01-05
2021-01-04
2020-12-29
2020-12-22
2020-12-15
2020-11-24
2020-11-17
Get this podcast on your
phone, FREE
